Prøve GULL - Gratis
We help companies accelerate processes across manufacturing, QA, QC, R&D
Express Pharma
|December 2025
Chandrachur Datta, Partner, Vector Consulting Group analyses the hidden costs of increasing unresolved deviations during production and how this operational fragility erodes regulatory trust, ultimately impacting profitability. In a free wheeling conversation with Viveka Roychowdhury, Datta also outlines some solutions that reduced error generation, speeded up incident investigation and the possible path ahead
-
To begin, could you explain why your organisation put together are report titled, From errors to excellence: A GMP-aligned approach to reducing incidents? And why is this discussion around USFDA-regulated manufacturing plants and incident management important?
In USFDA-regulated pharma plants, every deviation or unexpected event during manufacturing must be documented in the Batch Manufacturing Record (BMR). These incidents may include variations in machine speed, deviations in temperature or humidity, or any operational error. Once an incident is logged, it cannot be ignored. The root cause must be identified, and corrective and preventive actions (CAPA) must be determined before the batch can be released.
The challenge is that the number of such incidents is high across many plants, which delays batch release. These delays affect inventory, working capital, supply reliability, and sometimes force companies to expedite production or increase changeovers. Our study focused on understanding why these incidents occur so frequently and how to reduce them, improving supply chain stability and plant performance.
If this problem has been known for some time, why has it persisted? Pharma companies usually cite operator attrition and training gaps at the shop-floor level. Why hasn't the issue been resolved already?
You're right — the industry often attributes these incidents to operator mistakes, attrition, or insufficient training. As a result, the typical response has been to either train operators more or add additional checks and layers of supervision.
Denne historien er fra December 2025-utgaven av Express Pharma.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Express Pharma
Express Pharma
The invisible threat: Why packaging inks are the next major recall risk for pharma
Jatin Takkar, Head - Product Safety & Regulatory, Siegwerk India writes that packaging is emerging as a potential source of contamination due to unsafe ink chemistries. With global standards evolving, the industry must shift from reactive compliance to a proactive 'Safe by Design' approach that ensures packaging inks are as safe as the medicines they guard
4 mins
December 2025
Express Pharma
Beyond the machine: How intelligent packaging design elevates parenteral delivery
For sensitive parenteral products, the packaging is as critical as the drug itself. Uhlmann demonstrates how deep design competence turns packaging challenges into patient-centric solutions
2 mins
December 2025
Express Pharma
Ensuring Clean Room Integrity with Prime Clean Reset High-Speed Doors: Minimizing Air Permeability and Leakages
High-speed doors for clean rooms are specialized industrial doors essential for maintaining controlled environments.
3 mins
December 2025
Express Pharma
JULABO introduces Green Edition Refrigerated Circulators using natural refrigerants for sustainable lab cooling
JULABO launches its Green Edition range of refrigerated circulators designed to support laboratories in reducing carbon emissions, improving energy efficiency, and aligning with global environmental regulations
2 mins
December 2025
Express Pharma
Flexotherm Heating Tapes & Cords
Tempo's Flexotherm heating tapes and cords provide a safe, flexible, and efficient solution for maintaining solvent temperature across a wide range of industrial processes
1 mins
December 2025
Express Pharma
PRUV® -The original Sodium Stearyl Fumarate
JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago
5 mins
December 2025
Express Pharma
We continue to invest heavily in quality, regulatory compliance, and modernisation
Rishad Dadachanji, MD, Kaisha Packaging shares insights on emerging industry trends, new technologies showcased at CPhI & P-MEC, and how the Dadachanji Group is strengthening its integrated ecosystem to serve both domestic and global pharma markets
3 mins
December 2025
Express Pharma
Romaco begins local format part production in India
The Noack N 950E blister packaging machine with Indian-produced format parts to debut at CPHI & PMEC India 2025, followed by installation at the Romaco India Experience Centre in Hyderabad
4 mins
December 2025
Express Pharma
We built our business by obsessing over excipients
Shivang Zaveri, Director, Transchem Corporation Pharma; discusses Transchem's approach to excipients, innovation, and market strategy with Express Pharma.
2 mins
December 2025
Express Pharma
India is a cornerstone of Fette Compacting's global strategy
Ashok Gourish, Managing Director, Fette Compacting India, discusses India's pivotal role in the company's global growth, backed by expanded services, digital transformation support, and a strengthened Competence Center in Goa, in conversation with Express Pharma
5 mins
December 2025
Listen
Translate
Change font size
